Old Web
English
Sign In
Acemap
>
authorDetail
>
Mark Baer
Mark Baer
University of California, San Francisco
Antibody
lung injury
Medicine
Virology
Microbiology
4
Papers
154
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa -infected mice
2012
European Journal of Clinical Microbiology & Infectious Diseases
Yinglong Song
Mark Baer
Ruchika Srinivasan
Jun Lima
Geoffrey T. Yarranton
Christopher Bebbington
Susan V. Lynch
Show All
Source
Cite
Save
Citations (42)
Antibody to granulocyte macrophage colony-stimulating factor reduces the number of activated tissue macrophages and improves left ventricular function after myocardial infarction in a rat coronary artery ligation model.
2011
Journal of Cardiovascular Pharmacology
Robert S. Kellar
Jordan J. Lancaster
Hoang M. Thai
Elizabeth Juneman
Nicholle M. Johnson
Howard G. Byrne
Maribeth Stansifer
Reza Arsanjani
Mark Baer
Christopher Bebbington
Michael Flashner
Geoffrey T. Yarranton
Steven Goldman
Show All
Source
Cite
Save
Citations (11)
An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
2009
Infection and Immunity
Mark Baer
Teiji Sawa
Peter Flynn
Kenneth Luehrsen
David Martinez
Jeanine P. Wiener-Kronish
Geoffrey T. Yarranton
Christopher Bebbington
Show All
Source
Cite
Save
Citations (101)
Antibody-Antibiotic Combination Therapy Significantly Reduces Lung Injury and Improves Survival in Mice Infected withP. aeruginosa.
2009
ATS | American Thoracic Society International Conference
Yuanlin Song
Mark Baer
J. Lima
Hanjing Zhuo
Jeanine P. Wiener-Kronish
Christopher Bebbington
Susan V. Lynch
Show All
Source
Cite
Save
Citations (0)
1